Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 3 | Unknown | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Unknown | — |
The patient received only three doses of RabAvert for post-exposure prophylaxis; Case reference number US-BN-2026-000464 is a spontaneous case initially received from a consumer via Bavarian Nordic (reference number: CASE-002678) on 16-Mar-2026 and concerns a female patient of unknown age. The patient's medical history and concomitant medication details were not provided. On 25-Nov-2026, the patient was beaten by a dog. On the same date, the patient received the first dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at an unknown dose or route of administration, in arm for post-exposure prophylaxis and co-suspect immunoglobulins (batch number: unknown), at an unknown dose or route or site of administration for unknown indication. On 28-Nov-2025, three days after the first dose, the patient received the second dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at an unknown dose or route of administration, in arm. On 02-Dec-2025, seven days after the first dose, the patient received the third dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at an unknown dose or route of administration, in arm. As reported, the patient received only three doses of RabAvert since the dog ended up not having rabies (explicitly coded as 'incomplete course of vaccination'). At the time of the initial report, it is unknown if the patient experienced any adverse event due to RabAvert. No further information was provided.; Reporter's Comments: This case concerns a female patient of unknown age, who received only three doses of RabAvert vaccination, for an indication of post-exposure prophylaxis, which is considered as incomplete course of vaccination. Incomplete course of vaccination administered is expected as per company conventions. The patient's medical history and concomitant medication details were not provided. At the time of the initial report, it is unknown if the patient experienced any adverse event due to RabAvert vaccine. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious. For regulatory reporting purposes, this case is considered not related.; Sender's Comments: This case concerns a female patient of unknown age, who received only three doses of RabAvert vaccination, for an indication of post-exposure prophylaxis, which is considered as incomplete course of vaccination. Incomplete course of vaccination administered is expected as per company conventions. The patient's medical history and concomitant medication details were not provided. At the time of the initial report, it is unknown if the patient experienced any adverse event due to RabAvert vaccine. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious. For regulatory reporting purposes, this case is considered not related.
Comments: None.